Lung Cancer | John Heymach, MD, PhD

Striving for Consensus on the Optimal Management of Metastatic Non-Small Cell Lung Cancer — Faculty Presentation 4: Anti-angiogenic agents in NSCLC: Where we are, where we are going — Dr Heymach. CME information and select publications